Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1'-Deazo-Thiamin Diphosphate is a synthetic analog of thiamine diphosphate (ThDP), the active coenzyme form of vitamin B1. It features a structural modification at the 1' position of the thiazole ring (deaza substitution), which alters its electronic and binding properties compared to natural ThDP. Like ThDP, it can bind to and modulate enzymes that require thiamine diphosphate as a cofactor—such as transketolase and various dehydrogenases—but is primarily used in biochemical research to probe enzyme mechanisms or as an inhibitor/analog in structural studies[7][5]. It is not approved for therapeutic use and remains an experimental compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1'-deazo-thiamin diphosphate.